medac Gesellschaft für klinische Spezialpräparate mbH
USPTO Trademark & Patent Filings
Trademark applications and grants for Medac Gesellschaft Für Klinische Spezialpräparate Mbh. Medac Gesellschaft Für Klinische Spezialpräparate Mbh has 12 trademark applications. The latest application filed is for "MEDAC"
- Company Aliases
- medac Gesellschaft fur klinische Spezialpraparate mbH
- mbh spezialpraparate klinische fur gesellschaft medac
- Medac Gesellschaft Fur Klinische Spezialpraparate MBH - Wedel DE
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH - Theaterstr. DE
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH - Wedel DE
- Medac Gesellschaft fur Klinische Spezialpraparate mbH - Wedel DE
- medac Gesellschaft fur klinische Spezialpraparate mbH - Wedel N/A DE
| State Incorporated | GERMANY |
| Entity Type | LIMITED LIABILITY COMPANY |
| Address | Theaterstr. 6 Wedel GERMANY 22880 |
Trademarks Patents
| Patent Application | Date |
|---|---|
| LYOPHILISATE OF TREOSULFAN 20220031620 - 17/279200 Bialleck; Sebastian | 2022-02-03 |
| CRYSTALLINE FORM OF TREOSULFAN 20210387945 - 17/279157 Bialleck; Sebastian ; et al. | 2021-12-16 |
| TRANSFER DEVICE 20200297582 - 16/895323 SCHULDT-LIEB; Sonja ; et al. | 2020-09-24 |
| PROCESS FOR THE PREPARATION OF A FREEZE-DRIED PHARMACEUTICAL COMPOSITION CONTAINING MITOMYCIN C 20200276128 - 16/876505 Schuldt-Lieb; Sonja ; et al. | 2020-09-03 |
| PURIFICATION OF EPIDAUNORUBICIN 20170051001 - 15/307488 BINDERNAGEL; Holger ; et al. | 2017-02-23 |
| Transfer device for media, comprising a non-releasably lockable adapter 10,716,736 - 15/125,687 Schuldt-Lieb , et al. | 2020-07-21 |
| Transfer device for media, comprising a non-releasably lockable adapter 10,716,736 - 15/125,687 Schuldt-Lieb , et al. | 2020-07-21 |
| Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C 10,688,049 - 15/031,519 Schuldt-Lieb , et al. | 2020-06-23 |
| Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C 10,688,049 - 15/031,519 Schuldt-Lieb , et al. | 2020-06-23 |
| Purification of epidaunorubicin 10,081,652 - 15/307,488 Bindernagel , et al. September 25, 2 | 2018-09-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 